Quantum Cyber N.V.
QUCYNasdaq
$1.23
↑ +3.4%Jul 17 close · end-of-day
Price
1Y↓ -32.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$7.4M
Enterprise Value
$2.7M
P/E
—
P/S
13.7
P/B
1.6
EV/EBITDA
—
PEG
—
FCF Yield
-148.9%
Dividend Yield
—
Revenue (TTM)
$537,080.00
Net Income (TTM)
-$16.2M
Free Cash Flow (TTM)
-$11.0M
Gross Margin
72.6%
Operating Margin
-3005.0%
Net Margin
-3018.3%
ROE
-353.2%
ROIC
—
Debt / Equity
—
Net Cash
$4.7M
Return 1Y
-33.1%
Company profile
Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.
- CEO
- Guido Baechler
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 30
- Website
- mainzbiomed.com
Management & directors
- Baechler GuidoChief Executive Officer
- Caragol William JChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
QUCY Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.43↓ -70.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2024 | FY2025 |
|---|---|---|
| Revenue | $893,991.00 | $537,080.00 |
| Gross profit | $574,883.00 | $389,792.00 |
| Operating income | -$18.8M | -$16.1M |
| Net income | -$21.6M | -$16.2M |
| Diluted EPS | -$21.91 | -$2.70 |
| Operating cash flow | -$17.3M | -$11.0M |
| Free cash flow | -$17.4M | -$11.0M |
| Gross margin | 64.3% | 72.6% |
| Operating margin | -2099.9% | -3005.0% |
| Net margin | -2416.0% | -3018.3% |
| Line item | Q1 '23 | Q1 '25 | Q1 '26 |
|---|---|---|---|
| Revenue | $1.00 | — | — |
| Gross profit | — | — | — |
| Operating income | — | -$2.7M | -$2.5M |
| Net income | — | -$5.0M | -$5.1M |
| Diluted EPS | — | -$1.46 | -$0.43 |
| Operating cash flow | — | -$3.9M | -$2.7M |
| Free cash flow | — | -$3.9M | -$2.7M |
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
Company news
Jul 16, 2026
- 4d agoQuantum Cyber Completes Acquisition of U.S.-Based Manufacturing Facility in Bridgeport, Connecticutfinance.yahoo.com
- 4d agoQuantum Cyber shares rise after subsidiary secures $2.1 million in new orders (QUCY)investorshub.advfn.com
- 4d agoQuantum Cyber Reports Approximately $2 Million of Purchase Orders for Quantum Drone Corporationfinance.yahoo.com
Jul 8, 2026
Jul 6, 2026
- 14d agoQuantum Cyber Sets 100,000-Drone Annual Production Goal for Planned Connecticut Facility (QUCY)investorshub.advfn.com
- 14d agoQuantum Cyber Targets Annual Production Capacity of 100,000 Drones combining Kamikaze, Interceptor, Surveillance, VTOL and long-range Phantom 950 at Planned Bridgeport, Connecticut Manufacturing Facilityfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-08 | Ben-Tzvi Avraham | Award | 137,141 | $0.00 | $0.00 | filing |
| 2026-05-08 | NATAN DAVID | Award | 137,141 | $0.00 | $0.00 | filing |
| 2026-02-13 | Dreismann Heiner | Award | 45,000 | $0.00 | $0.00 | filing |
| 2026-02-13 | BAECHLER GUIDO· Chief Executive Officer | Award | 440,000 | $0.00 | $0.00 | filing |
| 2026-02-13 | Tibbitts Gregory J | Award | 45,000 | $0.00 | $0.00 | filing |
| 2026-02-13 | Caragol William J· Chief Financial Officer | Award | 290,000 | $0.00 | $0.00 | filing |
| 2025-10-17 | Donahue Kevin Michael | Buy | 643,850 | $402,000.00 | $258.8B | filing |
| 2025-10-17 | Donahue Kevin Michael | Buy | 685,000 | $1.51 | $1.0M | filing |
Latest 8 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.